Aastrom Biosciences Inc (NASDAQ:ASTM)
CAPS Rating:
The regenerative medicine company engaged in clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on proprietary Tissue Repair Cell Technology.
RSS Headlines
Fool UK
Recs
Article from Zacks Biotech Guy - Jason Napodano - trying a strategy where I set 10% stops on all these and let the winners run.